Cardiovascular Toxicity and Titin Cross-Reactivity of Affinity-Enhanced TCR-Engineered T Cells Against HLA-A1 Restricted MAGE-A3 Antigen

被引：0
|
作者：
Maus, Marcela V. [1 ]
Linette, Gerald P. [2 ]
Stadtmauer, Edward A. [1 ]
Rapoport, Aaron P. [3 ]
Levine, Bruce L. [1 ]
Emery, Lyndsey A. [1 ]
Litzky, Leslie [1 ]
Binder-Scholl, Gwendolyn K. [4 ]
Smethurst, Dominic P. [4 ,5 ]
Gerry, Andrew B. [4 ]
Pumphrey, Nick J. [4 ]
Bennet, Alan [4 ]
Brewer, Joanna [4 ]
Harper, Jane [5 ]
Hassan, Namir [5 ]
Jakobsen, Bent K. [4 ,5 ]
Kalos, Michael [1 ]
June, Carl H. [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Adaptimmune Ltd, Abingdon, Oxon, England
[5] Immunocore Ltd, Abingdon, Oxon, England
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
59
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 7 条
  • [1] Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
    Linette, Gerald P.
    Stadtmauer, Edward A.
    Maus, Marcela V.
    Rapoport, Aaron P.
    Levine, Bruce L.
    Emery, Lyndsey
    Litzky, Leslie
    Bagg, Adam
    Carreno, Beatriz M.
    Cimino, Patrick J.
    Binder-Scholl, Gwendolyn K.
    Smethurst, Dominic P.
    Gerry, Andrew B.
    Pumphrey, Nick J.
    Bennett, Alan D.
    Brewer, Joanna E.
    Dukes, Joseph
    Harper, Jane
    Tayton-Martin, Helen K.
    Jakobsen, Bent K.
    Hassan, Namir J.
    Kalos, Michael
    June, Carl H.
    [J]. BLOOD, 2013, 122 (06) : 863 - 871
  • [2] Lysis of human chondrosarcoma cells by cytolytic T lymphocytes recognizing a MAGE-A3 antigen presented by HLA-A1 molecules
    Bluman, Eric M.
    Coulie, Pierre G.
    Sun Xiaojuan
    Machan, Jason
    Lin, Chouzao
    Meitner, Patricia A.
    Block, Joel A.
    Terek, Richard M.
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2007, 25 (05) : 678 - 684
  • [3] Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
    Cameron, Brian J.
    Gerry, Andrew B.
    Dukes, Joseph
    Harper, Jane V.
    Kannan, Vivekanandan
    Bianchi, Frayne C.
    Grand, Francis
    Brewer, Joanna E.
    Gupta, Minnal
    Plesa, Gabriela
    Bossi, Giovanna
    Vuidepot, Annelise
    Powlesland, Alex S.
    Legg, Alison
    Adams, Katherine J.
    Bennett, Alan D.
    Pumphrey, Nicholas J.
    Williams, Daniel D.
    Binder-Scholl, Gwendolyn
    Kulikovskaya, Irina
    Levine, Bruce L.
    Riley, James L.
    Varela-Rohena, Angel
    Stadtmauer, Edward A.
    Rapoport, Aaron P.
    Linette, Gerald P.
    June, Carl H.
    Hassan, Namir J.
    Kalos, Michael
    Jakobsen, Bent K.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (197)
  • [4] Engineered T-Cells Expressing An HLA-Restricted Affinity-Enhanced TCR In Advanced Multiple Myeloma Patients Post Auto-SCT Engraft and Are Associated With Encouraging Post Auto-SCT Responses
    Rapoport, Aaron P.
    Stadtmauer, Edward A.
    Vogl, Dan T.
    Weiss, Brendan M.
    Binder-Scholl, Gwendolyn K.
    Smethurst, Dominic P.
    Finklestein, Jeffrey
    Kulikovskaya, Irina
    Gupta, Minnal
    Brewer, Joanna E.
    Bennett, Alan D.
    Gerry, Andrew B.
    Pumphrey, Nicholas J.
    Tayton-Martin, Helen K.
    Ribeiro, Lilliam C.
    Badros, Ashraf
    Yanovich, Saul
    Akpek, Gorgun
    Kerr, Naseem
    Philip, Sunita
    Westphal, Sandra
    Levine, Bruce L.
    Jakobsen, Bent K.
    Kalos, Michael
    June, Carl H.
    [J]. BLOOD, 2013, 122 (21)
  • [5] Generation of Genetically Engineered T Cells Expressing Affinity-Enhanced TCR Anti-NY-ESO-1:HLA-A*02 with Potent and Target-Specific Antitumor Activity for the Treatment of Solid Tumors
    Rossetti, Rafaela
    Lima, Sarah C. G.
    Fantacini, Daianne M. C.
    Furtado, Izadora P.
    Silveira, Roberta M.
    Brand, Heloisa
    Ferreira, Andreza U. Q.
    Tsyrenov, Lev
    Shiku, Hiroshi
    Souza, Lucas E. B.
    Covas, Dimas T.
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 505 - 506
  • [6] Safety and Correlates of Clinical Response in an Early Phase Clinical Trial in Multiple Myeloma Patients Post Auto-SCT and Adoptive Immunotherapy with Engineered T Cells Expressing an HLA-A2 Restricted Affinity-Enhanced TCR for LAGE-1 and NY-ESO-1
    Levine, Bruce L.
    Rapoport, Aaron P.
    Stadtmauer, Edward A.
    Vogl, Dan T.
    Weiss, Brendan
    Binder-Scholl, Gwendolyn K.
    Smethurst, Dominic P.
    Finkelstein, Jeffrey
    Kulikovskaya, Irina
    Gupta, Minnal
    Suppa, Erica
    Brewer, Joanna E.
    Bennett, Alan D.
    Gerry, Andrew B.
    Pumphrey, Nick J.
    Tayton-Martin, Helen K.
    Williams, Daniel
    Zheng, Zhaohui
    Badros, Ashraf Z.
    Yanovich, Saul
    Akpek, Gorgon
    Kalos, Michael
    Jakobsen, Bent K.
    June, Carl H.
    [J]. MOLECULAR THERAPY, 2013, 21 : S114 - S114
  • [7] Prolonged T Cell Persistence, Homing to Marrow and Selective Targeting of Antigen Positive Tumor in Multiple Myeloma Patients Following Adoptive Transfer of T Cells Genetically Engineered to Express an Affinity-Enhanced T Cell Receptor Against the Cancer Testis Antigens NY-ESO-1 and Lage-1
    Kalos, Michael
    Rapoport, Aaron P.
    Stadtmauer, Edward A.
    Vogl, Dan T.
    Weiss, Brendan M.
    Binder-Scholl, Gwendolyn K.
    Smethurst, Dominic P.
    Kulikovskaya, Irina
    Gupta, Minnal
    Macatee, Timothy L.
    Finklestein, Jeffrey M.
    Brewer, Joanna E.
    Bennett, Alan D.
    Gerry, Andrew B.
    Pumphrey, Nick J.
    Tayton-Martin, Helen K.
    Veloso, Elizabeth
    Meng, Zhaohui
    Badros, Ashraf Z.
    Yanovich, Saul
    Akpek, Gorgun
    McConville, Holly
    Philip, Sunita
    Levine, Bruce L.
    Jakobsen, Bent K.
    June, Carl H.
    [J]. BLOOD, 2012, 120 (21)
1